Evidence map›Paper›PMID 16862167›Full record

ArticleBone marrow transplantation2006

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

P Reddy, K Johnson, J P Uberti, C Reynolds, S Silver, L Ayash, T M Braun, V Ratanatharathorn

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Rituximab therapy for membranous nephropathy: a systematic review.Clinical journal of the American Society of Nephrology : CJASN · 2009
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020
    Article
  8. [Clinical analysis of six cases with theZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2018
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

P ReddyBlood and Marrow Transplantation Program, Division of Hematology-Oncology, Department of Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. reddypr@umich.edu
K Johnson
J P Uberti
C Reynolds
S Silver
L Ayash
T M Braun
V Ratanatharathorn
University of Michigan–Ann Arbor · USThe Barbara Ann Karmanos Cancer Institute · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic graft-versus-host disease (cGVHD) is the most common late complication of allogeneic hematopoietic cell transplantation (HCT) causing significant morbidity and mortality. The kidneys are not considered a target organ for cGVHD in humans, although animal models show renal damage. Renal involvement in patients with cGVHD, presenting as nephrotic syndrome (NS), has rarely been reported in patients who received allogeneic transplantation. Herein we describe, by far, the largest series of nine patients with NS associated with cGVHD, including two patients who received a reduced-intensity regimen. Pathological features of membranous nephropathy were the most common finding on renal biopsy. The clinical course of the NS was temporally associated with the classical features of cGVHD in all but one of the nine cases. The clinicopathologic features of NS in our series as well as reports in the literature demonstrate an immunopathologic process typical of antibody-mediated damage consistent with cGVHD. Treatment directed against antibody-mediated damage, such as anti-B-cell antibody may play an important role in ameliorating NS associated with cGVHD.

Indexed as

AdultBiopsyChronic DiseaseFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansKidneyMaleMiddle AgedNephrotic SyndromeRetrospective StudiesTransplantation, Homologous

Identifiers

PMID16862167
OpenAlexW2087104914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.